Your browser doesn't support javascript.
loading
Association of omega 3 polyunsaturated fatty acids with incident chronic kidney disease: pooled analysis of 19 cohorts.
Ong, Kwok Leung; Marklund, Matti; Huang, Liping; Rye, Kerry-Anne; Hui, Nicholas; Pan, Xiong-Fei; Rebholz, Casey M; Kim, Hyunju; Steffen, Lyn M; van Westing, Anniek C; Geleijnse, Johanna M; Hoogeveen, Ellen K; Chen, Yun-Yu; Chien, Kuo-Liong; Fretts, Amanda M; Lemaitre, Rozenn N; Imamura, Fumiaki; Forouhi, Nita G; Wareham, Nicholas J; Birukov, Anna; Jäger, Susanne; Kuxhaus, Olga; Schulze, Matthias B; de Mello, Vanessa Derenji; Tuomilehto, Jaakko; Uusitupa, Matti; Lindström, Jaana; Tintle, Nathan; Harris, William S; Yamasaki, Keisuke; Hirakawa, Yoichiro; Ninomiya, Toshiharu; Tanaka, Toshiko; Ferrucci, Luigi; Bandinelli, Stefania; Virtanen, Jyrki K; Voutilainen, Ari; Jayasena, Tharusha; Thalamuthu, Anbupalam; Poljak, Anne; Bustamante, Sonia; Sachdev, Perminder S; Senn, Mackenzie K; Rich, Stephen S; Tsai, Michael Y; Wood, Alexis C; Laakso, Markku; Lankinen, Maria; Yang, Xiaowei; Sun, Liang.
Afiliação
  • Ong KL; Lipid Research Group, School of Biomedical Sciences, University of New South Wales, Sydney, NSW, Australia oklws@yahoo.com.hk.
  • Marklund M; The George Institute for Global Health, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.
  • Huang L; The Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Rye KA; Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden.
  • Hui N; The George Institute for Global Health, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.
  • Pan XF; Lipid Research Group, School of Biomedical Sciences, University of New South Wales, Sydney, NSW, Australia.
  • Rebholz CM; Lipid Research Group, School of Biomedical Sciences, University of New South Wales, Sydney, NSW, Australia.
  • Kim H; The George Institute for Global Health, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.
  • Steffen LM; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
  • van Westing AC; Shuangliu Institute of Women's and Children's Health, Shuangliu Maternal and Child Health Hospital, Chengdu, Sichuan, China.
  • Geleijnse JM; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Hoogeveen EK; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Chen YY; University of Minnesota School of Public Health, Minneapolis, MN, USA.
  • Chien KL; Division of Human Nutrition and Health, Wageningen University, Wageningen, The Netherlands.
  • Fretts AM; Division of Human Nutrition and Health, Wageningen University, Wageningen, The Netherlands.
  • Lemaitre RN; Department of Nephrology, Jeroen Bosch Hospital, Den Bosch, The Netherlands.
  • Imamura F; Institute of Epidemiology and Preventive Medicine College of Public Health, National Taiwan University, Taipei, Taiwan.
  • Forouhi NG; Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Wareham NJ; Heart Rhythm Center, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Jäger S; Institute of Epidemiology and Preventive Medicine College of Public Health, National Taiwan University, Taipei, Taiwan.
  • Kuxhaus O; Department of Epidemiology, University of Washington, Seattle, WA, USA.
  • Schulze MB; Department of Medicine, University of Washington, Seattle, WA, USA.
  • de Mello VD; MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.
  • Tuomilehto J; MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.
  • Uusitupa M; MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.
  • Lindström J; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Tintle N; German Center for Diabetes Research (DZD), München-Neuherberg, Germany.
  • Harris WS; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Yamasaki K; German Center for Diabetes Research (DZD), München-Neuherberg, Germany.
  • Hirakawa Y; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Ninomiya T; German Center for Diabetes Research (DZD), München-Neuherberg, Germany.
  • Tanaka T; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Ferrucci L; German Center for Diabetes Research (DZD), München-Neuherberg, Germany.
  • Bandinelli S; Institute of Nutritional Science, University of Potsdam, Potsdam, Germany.
  • Virtanen JK; Institute of Public Health and Clinical Nutrition, School of Medicine, University of Eastern Finland, Kuopio, Finland.
  • Voutilainen A; Population Health Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Jayasena T; Department of Public Health, University of Helsinki, Helsinki, Finland.
  • Thalamuthu A; Saudi Diabetes Research Group, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Poljak A; Institute of Public Health and Clinical Nutrition, School of Medicine, University of Eastern Finland, Kuopio, Finland.
  • Bustamante S; Population Health Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Sachdev PS; The Fatty Acid Research Institute, Sioux Falls, SD, USA.
  • Senn MK; Department of Population Health Nursing Science, College of Nursing, University of Illinois-Chicago, Chicago, IL, USA.
  • Rich SS; The Fatty Acid Research Institute, Sioux Falls, SD, USA.
  • Tsai MY; Department of Internal Medicine, Sanford School of Medicine, University of South Dakota, Sioux Falls, SD, USA.
  • Wood AC; Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Laakso M; Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Lankinen M; Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Yang X; Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Sun L; Translational Gerontology Branch, National Institute on Aging, National Institute of Health, Baltimore, MD, USA.
BMJ ; 380: e072909, 2023 01 18.
Article em En | MEDLINE | ID: mdl-36653033
OBJECTIVE: To assess the prospective associations of circulating levels of omega 3 polyunsaturated fatty acid (n-3 PUFA) biomarkers (including plant derived α linolenic acid and seafood derived eicosapentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid) with incident chronic kidney disease (CKD). DESIGN: Pooled analysis. DATA SOURCES: A consortium of 19 studies from 12 countries identified up to May 2020. STUDY SELECTION: Prospective studies with measured n-3 PUFA biomarker data and incident CKD based on estimated glomerular filtration rate. DATA EXTRACTION AND SYNTHESIS: Each participating cohort conducted de novo analysis with prespecified and consistent exposures, outcomes, covariates, and models. The results were pooled across cohorts using inverse variance weighted meta-analysis. MAIN OUTCOME MEASURES: Primary outcome of incident CKD was defined as new onset estimated glomerular filtration rate <60 mL/min/1.73 m2. In a sensitivity analysis, incident CKD was defined as new onset estimated glomerular filtration rate <60 mL/min/1.73 m2 and <75% of baseline rate. RESULTS: 25 570 participants were included in the primary outcome analysis and 4944 (19.3%) developed incident CKD during follow-up (weighted median 11.3 years). In multivariable adjusted models, higher levels of total seafood n-3 PUFAs were associated with a lower incident CKD risk (relative risk per interquintile range 0.92, 95% confidence interval 0.86 to 0.98; P=0.009, I2=9.9%). In categorical analyses, participants with total seafood n-3 PUFA level in the highest fifth had 13% lower risk of incident CKD compared with those in the lowest fifth (0.87, 0.80 to 0.96; P=0.005, I2=0.0%). Plant derived α linolenic acid levels were not associated with incident CKD (1.00, 0.94 to 1.06; P=0.94, I2=5.8%). Similar results were obtained in the sensitivity analysis. The association appeared consistent across subgroups by age (≥60 v <60 years), estimated glomerular filtration rate (60-89 v ≥90 mL/min/1.73 m2), hypertension, diabetes, and coronary heart disease at baseline. CONCLUSIONS: Higher seafood derived n-3 PUFA levels were associated with lower risk of incident CKD, although this association was not found for plant derived n-3 PUFAs. These results support a favourable role for seafood derived n-3 PUFAs in preventing CKD.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácidos Graxos Ômega-3 / Insuficiência Renal Crônica Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácidos Graxos Ômega-3 / Insuficiência Renal Crônica Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article